CTEV
Get informed when a big investor buys or sells
+ FollowOvervalued by 223.4% based on the discounted cash flow analysis.
| Market cap | $671.51 Million |
|---|---|
| Enterprise Value | $5.28 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-17.3 |
| Beta | 0.79 |
| Outstanding Shares | 16,964,960 |
| P/E Ratio | -2.32 |
|---|---|
| PEG | 42.49 |
| Price to Sales | 0.67 |
| Price to Book Ratio | -2.3 |
| Enterprise Value to Revenue | 5.31 |
| Enterprise Value to EBIT | 165.7 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.88 |
| Debt to Equity | -15.69 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5436▲ 25.54% |
|---|---|
| Total Calls | 67,700▼ 34.53% |
| Total Puts | 36,800▲ 23.49% |
Holdings and activity of institutional investors.
| Ownership % | 86.12%▲ 0.38% |
|---|---|
| Total Invested | $231.48M▼ 61.58% |
| Investors Holding | 99▼ 11.00% |
No data
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-...